Related Experiment Videos
[Preparation of a cytostatic-containing bone cement]
Die Pharmazie
|February 1, 1987
Summary
Incorporating cytostatic drugs into bone glue for local cancer therapy is effective. Methotrexate and doxorubicin were stable and released appropriately in vitro, maintaining bone glue integrity.
Area of Science:
- Oncology
- Biomaterials Science
- Pharmacology
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Beneficial antioxidant status of piglets from sows fed selenomethionine compared with piglets from sows fed sodium selenite.
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)·2019
Impaired post-irradiation survival of cyclooxygenase-2-deficient mice.
Physiological research·2018
Biomechanical stress in myocardial infarctions: can endothelin-1 and growth differentiation factor 15 serve as immunohistochemical markers?
International journal of legal medicine·2017
An independent assessment of reliability of the Melbourne Cerebral Palsy Hip Classification System.
Journal of children's orthopaedics·2017
Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026